Renaissance Technologies’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,079,515
| Closed | -$93K | – | 4288 |
|
|
2023
Q3 | $93K | Buy |
1,079,515
+384,600
| +55% | +$33.1K | ﹤0.01% | 3267 |
|
|
2023
Q2 | $389K | Sell |
694,915
-2,500
| -0.4% | -$1.4K | ﹤0.01% | 3003 |
|
|
2023
Q1 | $795K | Sell |
697,415
-17,800
| -2% | -$20.3K | ﹤0.01% | 2624 |
|
|
2022
Q4 | $801K | Sell |
715,215
-56,792
| -7% | -$63.6K | ﹤0.01% | 2666 |
|
|
2022
Q3 | $1.62M | Sell |
772,007
-68,500
| -8% | -$144K | ﹤0.01% | 2169 |
|
|
2022
Q2 | $1.14M | Sell |
840,507
-146,216
| -15% | -$199K | ﹤0.01% | 2619 |
|
|
2022
Q1 | $1.67M | Sell |
986,723
-369,051
| -27% | -$624K | ﹤0.01% | 2362 |
|
|
2021
Q4 | $1.46M | Buy |
1,355,774
+438,725
| +48% | +$474K | ﹤0.01% | 2380 |
|
|
2021
Q3 | $2.71M | Sell |
917,049
-56,053
| -6% | -$165K | ﹤0.01% | 1868 |
|
|
2021
Q2 | $2.93M | Buy |
973,102
+6,595
| +0.7% | +$19.9K | ﹤0.01% | 1993 |
|
|
2021
Q1 | $3.15M | Sell |
966,507
-56,700
| -6% | -$185K | ﹤0.01% | 1933 |
|
|
2020
Q4 | $4.22M | Buy |
1,023,207
+29,000
| +3% | +$119K | ﹤0.01% | 1701 |
|
|
2020
Q3 | $5.38M | Buy |
994,207
+42,900
| +5% | +$232K | 0.01% | 1529 |
|
|
2020
Q2 | $6.4M | Sell |
951,307
-71,400
| -7% | -$481K | 0.01% | 1484 |
|
|
2020
Q1 | $3.25M | Buy |
1,022,707
+512,595
| +100% | +$1.63M | ﹤0.01% | 1804 |
|
|
2019
Q4 | $3.57M | Buy |
510,112
+379,300
| +290% | +$2.65M | ﹤0.01% | 2048 |
|
|
2019
Q3 | $502K | Buy |
130,812
+94,400
| +259% | +$362K | ﹤0.01% | 2868 |
|
|
2019
Q2 | $138K | Buy |
+36,412
| New | +$138K | ﹤0.01% | 3362 |
|